Years of Struggle Better Strategy With Quality Business

Rinani Group is a leading independently-managed corporate finance services firm specialising in providing the most optimum corporate exercise strategy to help business owners build their business at different stages of their business cycle.

Who We Are
Leading Finance Services Firm

About Rinani

Why Rinani Group?

Understand your business needs

We will come up with solutions that cater to your business plans, addressing your business concerns.

Valuable and quality corporate finance services

We provide quality corporate finance advice, solutions and strategies.

Effective communication

We will communicate promptly on any company matters with your management team, fostering a strong working relationship and highlight arising issues during our course of work.

What we provides

Get Exceptional
Service For Growth

Rinani Group have a deep and proven understanding across a broad spectrum of different industries and are at the forefront of market trends.

Risk Management

Share with you the risks and opportunities in different financial...

Read More

Financial Planning

Identify, select and choose a suitable range of products that matches your needs ...

Read More

Financing Services

We take pride in our enduring relationships with financial institutions...

Read More

Merger and Acquisition

Acquisitions, divestments, buy-outs and reverse take-overs for organic growth...

Read More

Equity and Debt Fund Raising

We advise on fundraising plans via equity and/or debt instrument.

Read More

Corporate Restructuring

Our scope covers both distressed and non-distressed companies.

Read More
Read the articles

What’s Happening

Rinani Group emerges as Malaysian Genomics's substantial shareholder

KUALA LUMPUR: Malaysian Genomics Resource Centre Bhd has announced that Rinani Group Bhd has emerged as a substantial shareholder in the group with a 5.85% stake. “We are excited to have Rinani Group on board as a substantial shareholder. Their investment comes at a pivotal time as we are transitioning towards biopharmaceuticals and pursuing various growth initiatives,” group executive chairman Azri Azerai said in a statement. Azri emphasised that the addition of Rinani as a substantial shareholder would play a crucial role in the group's restructuring and next phase of growth. "Their involvement brings a wealth of opportunities in life sciences and its applications, which aligns with our growth strategy," he said.


Years Experiences


Expert Consultants


Our Trusted Clients


Projects Delivered